ORI Capital
Hong Kong, Hong Kong · Pre-seed → Series A
Their stated focus (public profile)
ORI Capital is a venture capital firm founded in 2015 that invests in innovative early-stage biotech companies globally. Their focus areas include diagnostics, drug delivery, and therapeutics targeting diseases with the highest mortality rates: cancer, cardiovascular, and neurodegenerative diseases.
Stages: Pre-seed → Series A
Sectors: Life sciences, Medtech
On file: 7 partners on record · 4 companies on record
Website: ori-capital.com
This perch was compiled from public sources — filings, the fund’s own site, public write-ups. None of it is the fund’s own words.
Is this your fund? Request a correction or removal.
Search the funds we have on file
Looking for investors? Search the funds we have on file — what they back, where they are, and whether your raise fits. Sign in and Percy matches you to the right ones.
Looking to claim your own fund? Start here →
This perch was compiled from public sources — filings, the fund’s own site, public write-ups. None of it is the fund’s own words.
Funds closest to this thesis
Ordered by how close each thesis sits to this one.
Is this your fund? Request a correction or removal.